期刊文献+

弓形虫棒状体蛋白2和膜表面蛋白1融合基因的克隆与表达 被引量:5

Cloning and Expression of the Fused Gene of Rhoptry Protein ROP2 and Major Surface Protein P30 from Toxoplasma gondii
下载PDF
导出
摘要 目的进行弓形虫棒状体蛋白2(ROP2)和膜表面蛋白1(P30)融合基因的克隆与表达,为弓形虫ROP2-P30基因工程复合抗原的制备做准备。方法半套式PCR扩增编码弓形虫P30的基因片段,克隆至已构建成功的重组质粒pUC119/ROP2中,经PCR和酶切鉴定正确的重组质粒pUC119/ROP2-P30再以SacⅠ/HindⅢ双酶切克隆至表达载体pET28b上,鉴定正确的重组质粒pET28b/ROP2-P30转化大肠埃希菌表达菌株BL21-Codon Plus(DE3)-RIL,经异丙基-β-D-硫代半乳糖苷(IPTG)诱导表达。结果从弓形虫RH株基因组DNA中扩增出700 bp P30基因片段,成功构建重组质粒pET28b/ROP2-P30,该质粒经PCR和酶切鉴定,与预期结果一致,并在大肠埃希菌中高效表达,产生相对分子质量(Mr)约为69 000的重组目的蛋白。结论弓形虫ROP2和P301融合基因克隆成功,并表达出预期的复合重组蛋白ROP2-P30。 Objective To clone and express the fused gene fragment coding rhoptry protein ROP2 and major surface protein P30 from Toxoplasma gondii as a preparation for the construction of the complex ROP2-P30 antigen by gene engineering. Methods The gene fragment encoding P30 was amplified by PCR from T.gondii RH strain and subeloned into the recombinant plasmid pUC119/ROP2 already constructed. The recombinant plasmid pUC119/ROP2-P30 was digested by Sac Ⅰ/HindⅢ and inserted into the same site of expression vector pET28b. The recombinant plasmid of pET28b/ROP2-P30 was transformed to E.coli and expressed under the induction of IPTG. Results The gene fragment 700 bp encoding P30 was obtained from the total DNA of T.gondii by PCR. The recombinant plasmid pET28b/ROP2-P30 was successfully constructed, which was highly expressed in E.coli, a fusion protein with molecular weight of 69 000. Conclusion The fusion geue encoding the rhoptry protein ROP2 and the major surface protein P30 of T. gondii has been successfully cloned and expressed to be an expected recombinant fusion protein ROP2-P30 with molecular weight 69 000.
出处 《中国寄生虫学与寄生虫病杂志》 CAS CSCD 北大核心 2005年第6期415-418,共4页 Chinese Journal of Parasitology and Parasitic Diseases
关键词 弓形虫 棒状体蛋白 膜表面蛋白1 克隆 表达 Toxoplasma gondii ROP2 P30 Cloning Expression
  • 相关文献

参考文献9

  • 1Saavedra R,Becerril MA,Dubeaux C,et al.Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii[J].Infect Immun,1996,64:3858-3862.
  • 2Khan IA,Kenneth HE,Kasper LH.A purified parasite antigen(P30) mediated CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice[J].J Immunol,1991,147:3501-3506.
  • 3Mineo JR,Mcleod R,Mack D,et al.Antibodies to Toxoplasma gondii major surface protein(SAG1,P30) inhibit infection of host cell and produced in murine after peroral infection[J].J Immunol,1993,150:3951-3964.
  • 4Aosai F,Mun HS,Norose K,et al.Protective immunity induced by vaccination with SAG1 gene-transfected cells against Toxoplasma gondii infection in mice[J].Microbiol Immunol,1999,43:87-91.
  • 5Burg JL,Perelman D,Kasper LH,et al.Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii[J].J Immunol,1988,141:3584-3591.
  • 6Alexandre J,Jebbari H,Bluethmann H,et al.Immunological control of T.gondii and appropriate vaccine design[J].Curr Top Microbiol Immunol,1996,219:188-190.
  • 7Nielsen HV,Lauemoller SL,Christiansen L,et al.Complete protection against lethal T.gondii infection in mice immunized with a plasmid encoding the SAG1 gene[J].Infect Immun,1999,67:6356-6363.
  • 8Chen XG,Gong Y,Li H,et al.High level expression and purification of immunogenic recombinant SAG1 (P30) of Toxoplasma gondii in Escherichia coli [J].Protein Expression Purification,2001,23:33-37.
  • 9Fachado A,Rodriguez A,Angel SO,et al.Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice[J].Vaccine,2003,21:1327-1335.

同被引文献40

  • 1侯俊清,黄志红,李铁强.丝裂霉素加透明质酸酶膀胱灌注预防膀胱癌电切术后复发[J].第四军医大学学报,2006,27(13):1247-1247. 被引量:1
  • 2任智慧 朱开春 金华利 等.透明质酸酶和硫酸软骨素增强外源基因在机体内的表达.农业生物技术学报,2005,13:14-17.
  • 3Dubey J P, Hill DE, Jones J L, et al. Prevalence of viable Toxoplasma gondii in beef,chicken,and pork from retail meat stores in the United States: risk assessment to consumers [J]. J Parasitol, 2005,91(5 ): 1082-1093.
  • 4Bhopale GM. Development of a vaccine for toxoplasmosis: current status[J]. Microbes Infect,2003,5(5 ):457-462.
  • 5Dlugonska H,Gatkowska J,Kur J,et al. The vaccines against toxoplasmosis-current status of the studies[J]. Wiad Parazytol, 2007, 53(3) : 195-- 201.
  • 6Nielsen HV, Lauemoller SL, Christiansen L, et al. Complete protection against lethal T. gondii infection in mice immunized with a plasmid encoding the SAG1 gene[J]. Infect Immun,1999,67(12) : 6366--6363.
  • 7Naguleswaran A,Fialho AM,Chaudhari A.et al. Azurin like prorein blocks invasion of Toxoplasma gondii through potential in teractions with parasite surface antigen SAG1[J]. Antimierob A gents Chemother,2008,52(2):402-408.
  • 8Leyva R, Herion P, Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii[J]. Parasitol Res,2001,87(1) :70--79.
  • 9Eeheverria PC, Miguel N, Costas M, et al. Potent antigen specific immunity to Toxoplasma gondii in adjuvant-free vaccination system using ROP2-Leishmania infantum Hsp83 fusion protein[J]. Vaccine,2006,24 (19) :4102--4110.
  • 10Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis[J]. Parasitol,1995,110:S11-S16.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部